Common ash

Related Terms

Ash wood dust, flavonoids, Fraxini cortex, Fraxinus americana, Fraxinus elatior, Fraxinus excelsior, Fraxinus excelsior L., Fraxinus ornus L., hydroxycoumarins, Oleaceae (family), phenylethanoids, secoiridoid glucosides, white ash.
Combination product (examples): Phytodolor? (aspen, ash, goldenrod), Rebixiao granule (RBXG) (ash bark, Smilax glabra rhizome).
Note: This monograph does not include other unrelated species with the common name ash, such as Mountain ash (Sorbus spp.) or Prickly ash (Zanthoxylum spp.).

Background

Ash has been used since the time of the Native Americans and the early settlers of the Americas. The Native Americans supposedly showed the medicinal properties of nearly every portion of the tree to the settlers. Traditionally, ash has been used to treat external cancerous growths, itching, parasitic worms, and fever. It has also been used as an antiseptic, diuretic, aphrodisiac, and appetite stimulant.
Today, ash is still used for many conditions, including gouty arthritis, inflammation and pain. It may also be used as a general antimicrobial. It is commonly used in Europe in a variety of combination products. However, little human evidence exists, and only a few scientific studies have been carried out to support any of these claims.

Evidence Table

These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. GRADE *
These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. GRADE *


Ash has been historically noted for its anti-inflammatory and pain-relieving properties, but there is little scientific evidence currently available to support these uses.

C


Ash has been historically noted for its anti-inflammatory and pain-relieving properties, but there is little scientific evidence currently available to support these uses.

C
* Key to grades

A: Strong scientific evidence for this use
B: Good scientific evidence for this use
C: Unclear scientific evidence for this use
D: Fair scientific evidence for this use (it may not work)
F: Strong scientific evidence against this use (it likley does not work)
* Key to grades

A: Strong scientific evidence for this use
B: Good scientific evidence for this use
C: Unclear scientific evidence for this use
D: Fair scientific evidence for this use (it may not work)
F: Strong scientific evidence against this use (it likley does not work)

Tradition / Theory

The below uses are based on tradition, scientific theories, or limited research. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. There may be other proposed uses that are not listed below.

Dosing

Adults (over 18 years old)
There is no proven safe or effective dose for ash in adults.

Safety

The U.S. Food and Drug Administration does not strictly regulate herbs and supplements. There is no guarantee of strength, purity or safety of products, and effects may vary. You should always read product labels. If you have a medical condition, or are taking other drugs, herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy. Consult a healthcare provider immediately if you experience side effects.

Interactions

Interactions with Drugs
Ash may reduce blood uric acid concentrations and is not recommended for patients taking allopurinol or other drugs that lower uric acid levels.
Ash may increase the effect of pain relievers.
Ash may interfere with how antibiotics work in the body and are not recommended for patients undergoing antibiotic therapy.
Ash may increase the risk of bleeding when taken with drugs that increase the risk of bleeding. Some examples include aspirin, anticoagulants ("blood thinners") such as warfarin (Coumadin?) or heparin, anti-platelet drugs such as clopidogrel (Plavix?), and non-steroidal anti-inflammatory drugs such as ibuprofen (Motrin?, Advil?) or naproxen (Naprosyn?, Aleve?).
Ash may increase the effect of anti-inflammatory drugs.
Ash bark, leaves, and flowers may have antioxidant activities and interfere with drugs that may be affected by the activities of antioxidants.
Ash bark, leaves, and flowers (Fraxinus ornus) may possess antiviral activity and may increase the effect of antiviral drugs when taken together.
Ash is not recommended to be used in combination with drugs that alter the immune system.

Attribution

This information is based on a systematic review of scientific literature edited and peer-reviewed by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com).

Bibliography

De Blay F, Bessot JC, Pauli G. [New aero-allergens]. Rev Pneumol.Clin 1996;52(2):79-87.
Enriquez Palomec O, Hernandez Chavez L, Sarrazola Sanjuan DM, et al. [Aeroallergens, skin tests and allergic diseases in 1091 patients]. Rev Alerg.Mex. 1997;44(3):63-66.
Ji W, Zhu XX, Tan WF, et al. Effects of Rebixiao granules on blood uric acid in patients with repeatedly attacking acute gouty arthritis. Chin J Integr.Med 2005;11(1):15-21.
Klein-Galczinsky C. [Pharmacological and clinical effectiveness of a fixed phytogenic combination trembling poplar (Populus tremula), true goldenrod (Solidago virgaurea) and ash (Fraxinus excelsior) in mild to moderate rheumatic complaints]. Wien.Med Wochenschr. 1999;149(8-10):248-253.
Kostova I. Fraxinus ornus L. Fitoterapia 2001;72(5):471-480.
Liccardi G, D'Amato M, D'Amato G. Oleaceae pollinosis: a review. Int Arch Allergy Immunol 1996;111(3):210-217.
Malo J, Cartier A. Occupational asthma caused by exposure to ash wood dust (Fraxinus americana). Eur.Respir.J. 1989;2(4):385-387.
Mothes N, Horak F, Valenta R. Transition from a botanical to a molecular classification in tree pollen allergy: implications for diagnosis and therapy. Int Arch Allergy Immunol 2004;135(4):357-373.
Pauli G, Bessot JC, Hutt N, et al. [Pollen environment and its evaluation]. Rev Pneumol.Clin 1997;53(6):317-322.
Vallverdu A, Garcia-Ortega P, Martinez J, et al. Mercurialis annua: characterization of main allergens and cross-reactivity with other species. Int Arch Allergy Immunol 1997;112(4):356-364.
von Kruedener S, Schneider W, Elstner EF. A combination of Populus tremula, Solidago virgaurea and Fraxinus excelsior as an anti-inflammatory and antirheumatic drug. A short review. Arzneimittelforschung 1995;45(2):169-171.
Williams PB. Critical analysis of studies concerning reports of respiratory sensitization to certain wood dusts. Allergy Asthma Proc 2005;26(4):262-267.